AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2021
Apr 2, 2021
35460_dirs_2021-04-02_a761b6cc-0e2c-44e7-b765-9603008ce16c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2021-03-17
Reporting Person: LIND DOUGLAS (Director)
More from Enveric Biosciences, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 18